Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1997 | 06-1997 | 03-1997 | 12-1996 | 09-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,371 | 7,812 | 7,345 | 1,833 | 2,019 |
| Other current assets | 137 | 359 | 279 | 359 | 359 |
| TOTAL | $7,508 | $8,171 | $7,624 | $2,192 | $2,379 |
| Non-Current Assets | |||||
| PPE Net | 263 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 29 | 0 | 0 | 0 | 0 |
| TOTAL | $292 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $7,650 | $8,298 | $7,744 | $2,318 | $2,949 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 178 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 125 | N/A | N/A | N/A | N/A |
| Other current liabilities | 900 | N/A | N/A | N/A | N/A |
| TOTAL | $1,203 | $1,324 | $102 | $322 | $174 |
| Non-Current Liabilities | |||||
| TOTAL | $313 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,516 | $1,324 | $102 | $322 | $174 |
| Shareholders' Equity | |||||
| Common Shares | 18,206 | 17,626 | 17,631 | 11,464 | 11,661 |
| Retained earnings | -12,166 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | 0 | -11,090 | 0 | 0 | 0 |
| TOTAL | $6,134 | $6,536 | $17,631 | $11,464 | $11,661 |
| Total Liabilities And Equity | $7,650 | $7,860 | $17,733 | $11,786 | $11,835 |